Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?

Mattia C. F. Prosperi, Sarah L. Ingham, Anthony Howell, Fiona Lalloo, Iain E. Buchan, Dafydd Gareth Evans. Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?. BMC Med. Inf. & Decision Making, 14:87, 2014. [doi]

Abstract

Abstract is missing.